Posts tagged as 'pharmaceutical supply chain'

State of the Pharmaceutical Supply Chain: Key Takeaways from LogiPharma US 2016

Dr. MadhavDurbha

Pharmaceutical Supply ChainPart of what makes my job very exciting is attending conferences. These events provide great opportunities to share, learn, network, and have fun. Earlier this week, I attended the LogiPharma conference, a wonderful event for supply chain professionals working in the pharmaceutical industry. Apart from taking part in numerous interactive presentations and roundtables, I had the opportunity to host a luncheon alongside my colleague, Bill Dubois, for a packed room of pharmaceutical industry executives and SCM practitioners.

All-in-all, it was a great validation of my point of view about where the pharma industry is with regards to its supply chain challenges, maturity and where it needs to go. In this blog, I want to share some key challenges faced by the pharma industry and pharmaceutical supply chains. And, in a future blog I will share some recommendations in light of these challenges:

1. Revenue pressures: With several blockbuster drug patents expiring (a.k.a. “patent cliff”) and with patent extensions harder to come by, large pharma companies are looking for opportunities to unlock additional value within their enterprises and across the value network as revenues remain under pressure.

Read the full story

Kinaxis life sciences newsletter: Featuring complimentary analyst case study report on Amgen

LoriSmith
  • by Lori Smith
  • Published

We are in the final days for offering complimentary access to the Kinaxis life sciences newsletter, which includes a Gartner Case Study: How Amgen Reinvigorated Its Supply Planning Process (Barry Blake, Hussain Mooraj: May 18, 2011).  According to the Gartner Case study, long supply cycle times require life science manufacturers to balance supply commitments, capacity management and product […]

Read the full story

Kinaxis life sciences newsletter: Featuring complimentary analyst case study report on Amgen

LoriSmith
  • by Lori Smith
  • Published

We recently produced a newsletter which includes complimentary access to a 6-page Gartner report titled Case Study: How Amgen Reinvigorated Its Supply Planning Process (Barry Blake, Hussain Mooraj: May 18, 2011) This Case Study provides insights on how Amgen transformed its supply planning processes and enabled rapid planning capabilities, with advanced planning capabilities and systems. […]

Read the full story

Cross industry knowledge transfer: Can lessons learned in Pharma apply to product obsolescence in High Tech Electronics?

MartinBuckley

I was talking to another consultant recently about issues one of their customers had with obsolescence in the high tech electronics industry. He said with all the rapid advances in technology, it is becoming increasingly difficult to avoid the effects of product obsolescence and its effects on margins, scrap, and inventory levels. He asked me […]

Read the full story

Transforming the Pharma Supply Chain Part 2

KerryZuber
  • by Kerry Zuber
  • Published

Taking note of best practices across industries As mentioned in Part 1 of this post, despite the unique aspects of the Pharma industry, the bulk of the supply chain management issues are largely common to many other industries.  And without the same degree of supply chain focus that is present in the high tech space […]

Read the full story

Transforming the Pharma Supply Chain Part 1

KerryZuber
  • by Kerry Zuber
  • Published

Can you achieve an acceptable level of supply availability without the current waste? There is no question that the Pharma industry must deal with a unique combination of supply chain and regulatory issues to meet its obligations to consumers, supply chain partners and shareholders. For some biotech companies, availability of their products are literally a […]

Read the full story

Startling supply chain stats from Gartner Healthcare Exchange

TrevorMiles
  • by Trevor Miles
  • Published

Having had some disagreement with a previous post by Kevin O’Marah of Gartner about S&OP, I was very pleased to get his weekly “First Thing Monday” in my inbox the other day.  It is titled “Healthcare Needs Supply Chain … Stat!”  Yes, it does.  Like Kevin mentions, I too have played at being US President […]

Read the full story

Safeguard the pharmaceutical supply chain

MartinBuckley

Special Notice: Kinaxis would like to invite the public to participate in an open Twitter chat about S&OP trends and strategies.  Follow the discussion tomorrow (Oct 5th) from 1:00pm – 2:00pm EDT using the hashtag #SOPchat.  Come participate in what we hope will be a lively and valuable conversation by posting your questions and opinions. Companies […]

Read the full story